Dexamethasone inhibits ischemia-induced transient reduction of neurotrophin-3 mRNA in rat hippocampal neurons

Neuroreport. 1998 Oct 26;9(15):3477-80. doi: 10.1097/00001756-199810260-00026.

Abstract

Dexamethasone (DEX) increases the expression of neurotrophin-3 (NT-3) in normal rat hippocampal neurons, whereas transient forebrain ischemia reduces the NT-3 mRNA level. The effect of DEX on the expression of NT-3 mRNA in injured brain cells after ischemia has not been investigated, however. Using in situ hybridization and ribonuclease protection assay methods, we studied NT-3 mRNA expression in rats with and without DEX administration after transient forebrain ischemia. Without DEX treatment, NT-3 mRNA was down-regulated in the hippocampal neurons at 2, 4, 12 h and returned to basal levels 24 h following ischemia. With DEX treatment, however, NT-3 mRNA showed no change at 2, 4 and 12 h and increased 24 h after ischemia. The results indicate that DEX inhibits ischemia-induced NT-3 mRNA down-regulation during the first 12 h and up-regulates NT-3 mRNA 24 h after ischemia. DEX administration might be effective in influencing some of the pathophysiological effects of ischemia in the hippocampus.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Brain Chemistry / drug effects
  • Brain Chemistry / physiology
  • Brain Ischemia / physiopathology*
  • Dentate Gyrus / blood supply
  • Dentate Gyrus / cytology
  • Dentate Gyrus / metabolism
  • Dexamethasone / pharmacology*
  • Gene Expression / drug effects
  • In Situ Hybridization
  • Male
  • Nerve Growth Factors / genetics*
  • Neurons / drug effects
  • Neurons / metabolism*
  • Neurotrophin 3
  • Prosencephalon / blood supply
  • Prosencephalon / cytology
  • Prosencephalon / metabolism
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Anti-Inflammatory Agents
  • Nerve Growth Factors
  • Neurotrophin 3
  • RNA, Messenger
  • Dexamethasone